Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 15, 2014, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $538.00 to $2,081,081.25.

Highlighted Stocks Traded by Insiders:

Mead Johnson Nutrition (MJN) - FREE Research Report

Golsby Stephen W, who is Director at Mead Johnson Nutrition, sold 5,000 shares at $96.83 on Dec. 15, 2014. Following this transaction, the Director owned 25,458 shares meaning that the stake was reduced by 16.42% with the 5,000-share transaction.

The shares most recently traded at $96.20, down $0.63, or 0.65% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,014
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 38,615
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 95,139

The average volume for Mead Johnson Nutrition has been 1.3 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $20.6 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 16.77% year-to-date as of the close of trading on Friday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.47%. The company has a P/E ratio of 30.4. Currently, there are 5 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings

rates Mead Johnson Nutrition as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Mead Johnson Nutrition Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

International (IBOC) - FREE Research Report

Guerra R David, who is Director at International, sold 12,028 shares at $23.41 on Dec. 15, 2014. Following this transaction, the Director owned 26,805 shares meaning that the stake was reduced by 30.97% with the 12,028-share transaction.

The shares most recently traded at $23.55, up $0.14, or 0.59% since the insider transaction. Historical insider transactions for International go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares sold: 4,000

The average volume for International has been 187,700 shares per day over the past 30 days. International has a market cap of $1.6 billion and is part of the financial sector and banking industry. Shares are down 10.7% year-to-date as of the close of trading on Friday.

International Bancshares Corporation, a financial holding company, provides commercial and retail banking services. The stock currently has a dividend yield of 2.21%. The company has a P/E ratio of 10.7. Currently, there are no analysts who rate International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBOC - FREE

TheStreet Quant Ratings

rates International as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, expanding profit margins, notable return on equity and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

International Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Document Security Systems (DSS) - FREE Research Report

Ronaldi Jeffrey, who is Ceo at Document Security Systems, bought 96,154 shares at $0.56 on Dec. 15, 2014. Following this transaction, the Ceo owned 171,187 shares meaning that the stake was boosted by 128.15% with the 96,154-share transaction.

Historical insider transactions for Document Security Systems go as follows:

  • 4-Week # shares bought: 4,588
  • 12-Week # shares bought: 4,588
  • 24-Week # shares bought: 4,588

The average volume for Document Security Systems has been 303,800 shares per day over the past 30 days. Document Security Systems has a market cap of $22.0 million and is part of the services sector and diversified services industry. Shares are down 74.88% year-to-date as of the close of trading on Friday.

Document Security Systems, Inc. develops, manufactures, markets, and sells paper and plastic products to protect information from unauthorized scanning, copying, and digital imaging in the United States and internationally. Currently, there is 1 analyst who rates Document Security Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DSS - FREE

TheStreet Quant Ratings

rates Document Security Systems as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and generally disappointing historical performance in the stock itself. Get the full

Document Security Systems Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null